Berotralstat HCL 150MG cap, oral trade name: orladeyo 150MG cap
Ended Awarded Last action
- Contract number
- 36C26024F0625
- Awardee
-
Biocryst Pharmaceuticals Inc. UEI MGXADJ6SCLJ5
- Awarding agency
-
Veterans Integrated Service Network 20
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $379,349
Award facts
- Contract value 100% obligated
- $379,348.93 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Earth City, MO 63045, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $4,723 | |
| Original award | $374,626 |
About this award
This federal contract award is for the delivery of BEROTRALSTAT HCL 150MG CAP (trade name ORLADEYO 150MG CAP) to the U.S. Department of Veterans Affairs (VA). The $379,348.93 contract was awarded to Biocryst Pharmaceuticals Inc., a biotechnology company that specializes in developing small molecule drugs for rare diseases. This is a Firm Fixed Price delivery order placed under Biocryst's Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB). The contract has an ultimate completion date of September 8, 2025.
Biocryst is a for-profit organization that has been registered to receive federal contract awards since 2006. The company primarily supplies pharmaceuticals to the VA, including ORLADEYO for hereditary angioedema and RAPIVAB for influenza treatment. This contract does not have a set-aside designation, indicating that Biocryst competed for the award in the open market without any small business or other preferential status.
Quick answers
Who was awarded contract 36C26024F0625?
36C26024F0625 was awarded to Biocryst Pharmaceuticals Inc. by Veterans Integrated Service Network 20 (Veterans Health Administration) on September 9, 2024.
How much is contract 36C26024F0625 worth?
The government has obligated $379,349 on 36C26024F0625.
Is contract 36C26024F0625 an order under another contract?
Yes. 36C26024F0625 is a delivery order under 36F79721D0166, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26024F0625 competed?
The extent of competition for 36C26024F0625 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award